Literature DB >> 24052782

Ethical issues in pediatric pharmacogenomics.

Kyle B Brothers1.   

Abstract

Keywords:  ethics; pediatrics; pharmacogenomics

Year:  2013        PMID： 24052782      PMCID： PMC3775553          DOI： 10.5863/1551-6776-18.3.192

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  22 in total

1.  The Pediatric Pharmacology Research Unit (PPRU) Network and its role in meeting pediatric labeling needs.

Authors:  S N Cohen
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Genetic research and health disparities.

Authors:  Pamela Sankar; Mildred K Cho; Celeste M Condit; Linda M Hunt; Barbara Koenig; Patricia Marshall; Sandra Soo-Jin Lee; Paul Spicer
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

Review 3.  Assent in paediatric research: theoretical and practical considerations.

Authors:  D S Wendler
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

4.  Race and ethnicity in the era of emerging pharmacogenomics.

Authors:  Lea Harty; Keith Johnson; Aidan Power
Journal:  J Clin Pharmacol       Date:  2006-04       Impact factor: 3.126

5.  Against the tide: arguments against respecting a minor's refusal of efficacious life-saving treatment.

Authors:  Lainie Friedman Ross
Journal:  Camb Q Healthc Ethics       Date:  2009       Impact factor: 1.284

6.  Genetic information and the family: are we our brother's keeper?

Authors:  Bartha Maria Knoppers
Journal:  Trends Biotechnol       Date:  2002-02       Impact factor: 19.536

7.  Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.

Authors:  E A Fargher; K Tricker; W Newman; R Elliott; S A Roberts; J L Shaffer; I Bruce; K Payne
Journal:  J Clin Pharm Ther       Date:  2007-04       Impact factor: 2.512

Review 8.  Parental refusals of medical treatment: the harm principle as threshold for state intervention.

Authors:  Douglas S Diekema
Journal:  Theor Med Bioeth       Date:  2004

9.  HLA-B*5701 clinical testing: early experience in the United States.

Authors:  Hawazin Faruki; Uwe Heine; Trisha Brown; Ruth Koester; Myla Lai-Goldman
Journal:  Pharmacogenet Genomics       Date:  2007-10       Impact factor: 2.089

10.  Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

Authors:  Felix W Frueh; Shashi Amur; Padmaja Mummaneni; Robert S Epstein; Ronald E Aubert; Teresa M DeLuca; Robert R Verbrugge; Gilbert J Burckart; Lawrence J Lesko
Journal:  Pharmacotherapy       Date:  2008-08       Impact factor: 4.705
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.